BioSig Technologies

A medical technology company pushing the boundaries of cardiac arrhythmia identification with the PURE EP™ Platform.

[BioSig Technologies @BioSig_Tech]

PURE EP™ enables full-spectrum signal reproducibility for vital aspects of data analysis not available from any other platform on the market.

PURE cardiac signals—without distortion—allow enhanced evaluation and confident treatment of even the most complex #arrhythmias. Learn more: https://t.co/3K0WkmR18q #Electrophysiology #EPeeps #MedTech

[BioSig Technologies @BioSig_Tech]

PURE EP™'s Near Field Tracking (NFT) tracks the reduction in the negative component of a unipolar intracardiac signal — even during ablation — providing tissue-specific visualization of physiologic data. https://t.co/Q0RSsi1OlV #Electrophysiology #EPeeps #MedTech #Cardiology

[BioSig Technologies @BioSig_Tech]

By focusing on signals above 200Hz, PURE EP™'s High Frequency Algorithm (HFA) adds visibility to cardiac frequency data and dynamically eliminates RF frequencies to retain clear focus on the signals targeted for ablation. https://t.co/3K0WkmR18q #Electrophysiology #EPeeps #MedTech #Cardiology

[BioSig Technologies @BioSig_Tech]

Happy Holidays from all of us at BioSig Technologies! #HolidaySeason

[BioSig Technologies @BioSig_Tech]

Now available under PURE EP™’s new subscription model, physicians can combine Heart Rate Cycle Length and Pattern Monitoring for Enhanced Visualization of Tachycardias. Learn more about our platform's unique Automatic Tachycardia Characterization (ATC) feature here: https://t.co/dzu8wH8x7O #Electrophysiology #EPeeps #MedTech #Cardiology

[BioSig Technologies @BioSig_Tech]

BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024. Read the press release here: https://t.co/QHMgepaFQ3 $BSGM #BusinessUpdate

[BioSig Technologies @BioSig_Tech]

Learn more about how we are revitalizing the power of unipolar signals with the unique Near Field Tracking (NFT) feature, only available on the PURE EP™ Platform. https://t.co/Q0RSsi2mbt #Electrophysiology #EPeeps #MedTech

[BioSig Technologies @BioSig_Tech]

This #Thanksgiving, we are grateful to the many incredible physicians that we have the honor of working with, and to the thousands across the globe that have dedicated their lives to transforming #arrhythmia care. #HappyThanksgiving

[BioSig Technologies @BioSig_Tech]

Subtle changes in complex tachycardias can be difficult to detect with the naked eye. PURE EP™'s Automatic Tachycardia Characterization (ATC) swiftly monitors #tachycardia heart rate cycle length in real-time, offering enhanced insight into tachycardia changes that might require closer examination. https://t.co/dzu8wH8x7O #EPeeps #Cardiology #Electrophysiology

[BioSig Technologies @BioSig_Tech]

Harnessing the power of automation, PURE EP™'s advanced Near Field Tracking (NFT) monitors changes in the local unipolar electrogram, empowering EPs with tissue specific feedback and characterization in real-time. Finally, accurate and reliable unipolar signal data is within reach.

Discover more here: https://t.co/uRmh7Ay5eT #EPeeps #MedTech #Electrophysiology

[BioSig Technologies @BioSig_Tech]

BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care.

PURE EP™ subscriber community now includes two of top three U.S. health systems in cardiology: Mayo Clinic-Phoenix and Cleveland Clinic. Read the news release here: https://t.co/du0BKDYs55 $BSGM #MedTech #Electrophysiology

[BioSig Technologies @BioSig_Tech]

With PURE EP™'s Near Field Tracking (NFT) feature, electrogram changes are color-coded so that EPs can easily distinguish between healthy and scarred tissue. Only available on the PURE EP™ Platform, NFT is empowering physicians with accurate and reliable unipolar data in real-time. https://t.co/uRmh7Ay5eT #Epeeps #Electrophysiology

[BioSig Technologies @BioSig_Tech]

Building on PURE EP™'s innovative tachycardia cycle length monitoring capabilities, the latest Automatic Tachycardia Characterization (ATC) feature now delivers real-time alerts to subtle changes in tachycardia conduction patterns. Learn more about PURE EP™ here: https://t.co/dzu8wH8x7O #EPeeps #MedTech #Innovation

[BioSig Technologies @BioSig_Tech]

Alongside @worldheartfed, we support this year’s theme to #UseHeart through our commitment to providing new levels of clarity in arrhythmia identification and visualization. Hear from our Principal Product Advisor, @ZacharyKoch13. https://t.co/W43fDCUu87 #WorldHeartDay #EPeeps

[BioSig Technologies @BioSig_Tech]

“In essence, PURE EP™ equips physicians with a wealth of additional information, enabling them to tailor therapy for each patient, recognizing that every heart is unique.”

Our very own Principal Advisor of Product Development, @ZacharyKoch13, discusses how we are pushing the boundaries of cardiac arrhythmia identification and advocating for the physicians we serve. https://t.co/7V8tUYF9RK $BSGM #EPeeps #MedTech #AfibAwarenessMonth #WorldHeartDay

[BioSig Technologies @BioSig_Tech]

We join @hrsonline in raising awareness for #AfibAwarenessMonth. With many patients turning to ablations, we're steadfast in our commitment to deliver pure intracardiac signals—without distortion—that allow for enhanced evaluation and confident treatment of the arrhythmias unique to each patient.

#HRS2023 data from @clevelandclinic demonstrated that PURE EP™’s unipolar capabilities provided real-time, tissue-specific feedback and time savings to optimize ablation procedures. Learn more about PURE EP™ here: https://t.co/3K0WkmR18q #EPeeps #MedTech #Innovation

[BioSig Technologies @BioSig_Tech]

75,000 ablations are performed annually in the U.S. and the cardiac ablation market is expected to exceed $14B by 2032.

For #AfibAwarenessMonth, we're shining a light on the fact that every minute counts in the electrophysiology lab. This begins with our commitment to provide unprecedented levels of signal clarity with our proprietary PURE EP™ Platform. Learn more about PURE EP™ here: https://t.co/0j4bKc2J6b

Learn more about #Afib from the Heart Rhythm Society. @hrsonline #EPeeps #MedTech #Innovation

[BioSig Technologies @BioSig_Tech]

This #AFibAwarenessMonth, we acknowledge EPs and their expertise in identifying abnormal electrical activity in the heart during procedures like cardiac ablation. It’s a challenging environment due to numerous sources of radiofrequency interference.

Our PURE EP™ Platform provides real-time, tissue-specific data that assists electrophysiologists to identify and treat arrhythmias with unprecedented clarity.

Learn more: https://t.co/3K0WkmR18q #EPeeps #MedTech #Innovation

[BioSig Technologies @BioSig_Tech]

Access the full-spectrum of intracardiac signal insights and realize the clinical, operational, and economic benefits of the PURE EP™ Platform.

Delivering a suite of configurable features, one-of-a-kind algorithms, and novel signal hygiene applications, PURE EP™ enables the freedom to explore relevant signal data for highly-tailored, efficient procedures. Check out the latest innovations in intracardiac signal visualization only available on PURE EP™: https://t.co/3K0WkmR18q #EPeeps #MedTech #Innovation

[BioSig Technologies @BioSig_Tech]

An incredible week of clinical training is complete! Prepare yourselves, EP community, as we get ready to share the latest advancements in intracardiac signal visualization. The future of EP is here and bringing with it PURE EP™’s newest suite of novel features and one-of-a-kind algorithms.

https://t.co/f2yOQmqG4A #MedTech #Innovation #EPeeps